These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 2912533)

  • 1. Metoclopramide versus metoclopramide and lorazepam. Superiority of combined therapy in the control of cisplatin-induced emesis.
    Gordon CJ; Pazdur R; Ziccarelli A; Cummings G; Al-Sarraf M
    Cancer; 1989 Feb; 63(3):578-82. PubMed ID: 2912533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiemetic control and prevention of side effects of anti-cancer therapy with lorazepam or diphenhydramine when used in combination with metoclopramide plus dexamethasone. A double-blind, randomized trial.
    Kris MG; Gralla RJ; Clark RA; Tyson LB; Groshen S
    Cancer; 1987 Dec; 60(11):2816-22. PubMed ID: 3315176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized, double-blind comparison of the antiemetic effect of metoclopramide and lorazepam with or without dexamethasone in patients receiving high-dose cisplatin.
    Stephens SH; Silvey VL; Wheeler RH
    Cancer; 1990 Aug; 66(3):443-6. PubMed ID: 2194642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of metoclopramide in acute and delayed chemotherapy induced emesis: a randomised double blind trial.
    O'Brien ME; Cullen MH; Woodroffe C; Kelly K; Burman C; Palmer K; Stuart NS; Blackledge GR; Sharpe J
    Br J Cancer; 1989 Nov; 60(5):759-63. PubMed ID: 2679853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical efficacy of lorazepam in prophylaxis of anticipatory, acute, and delayed nausea and vomiting induced by high doses of cisplatin. A prospective randomized trial.
    Malik IA; Khan WA; Qazilbash M; Ata E; Butt A; Khan MA
    Am J Clin Oncol; 1995 Apr; 18(2):170-5. PubMed ID: 7900711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiemetic regimens in outpatients receiving cisplatin and non-cisplatin chemotherapy. A randomized trial comparing high-dose metoclopramide plus methylprednisolone with and without lorazepam.
    González Barón M; Chacón JI; García Girón C; Ordóñez Gallego A; García de Paredes ML; Feliu J; Zamora P; Herranz C; Garrido P; Artal A
    Acta Oncol; 1991; 30(5):623-7. PubMed ID: 1892680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized, double-blind comparison of a prochlorperazine-based versus a metoclopramide-based antiemetic regimen in patients undergoing autologous bone marrow transplantation.
    Gilbert CJ; Ohly KV; Rosner G; Peters WP
    Cancer; 1995 Dec; 76(11):2330-7. PubMed ID: 8635039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Consecutive dose-finding trials adding lorazepam to the combination of metoclopramide plus dexamethasone: improved subjective effectiveness over the combination of diphenhydramine plus metoclopramide plus dexamethasone.
    Kris MG; Gralla RJ; Clark RA; Tyson LB; Fiore JJ; Kelsen DP; Groshen S
    Cancer Treat Rep; 1985 Nov; 69(11):1257-62. PubMed ID: 3912039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ondansetron and metoclopramide fail to prevent vomiting secondary to ultra-high-dose cisplatin-carboplatin chemotherapy.
    Fanning J; Hilgers RD
    Obstet Gynecol; 1994 Apr; 83(4):601-4. PubMed ID: 8134073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-dose metoclopramide + lorazepam versus low-dose metoclopramide + lorazepam + dehydrobenzperidol in the treatment of cisplatin-induced nausea and vomiting.
    Herrstedt J; Hannibal J; Hallas J; Andersen E; Laursen LC; Hansen M
    Ann Oncol; 1991 Mar; 2(3):223-7. PubMed ID: 2043493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of ondansetron-dexamethasone-lorazepam versus metoclopramide-dexamethasone-lorazepam in the control of cisplatin induced emesis.
    Manusirivithaya S; Chareoniam V; Isariyodom P; Sungsab D
    J Med Assoc Thai; 2001 Jul; 84(7):966-72. PubMed ID: 11759977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiemetic activity of oral lorazepam in addition to methylprednisolone and metoclopramide in the prophylactic treatment of vomiting induced by cisplatin. A double-blind, placebo-controlled study with crossover design.
    Clerico M; Bertetto O; Morandini MP; Cardinali C; Giaccone G
    Tumori; 1993 Apr; 79(2):119-22. PubMed ID: 8346563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The addition of ondansetron to the combination of metoclopramide, dexamethasone, and lorazepam did not improve vomiting prevention in patients receiving high-dose cisplatin.
    Baltzer L; Kris MG; Tyson LB; Rigas JR; Pisters KM
    Cancer; 1994 Feb; 73(3):720-3. PubMed ID: 8299095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized, double-blind, cross-over study comparing prochlorperazine and lorazepam with high-dose metoclopramide and lorazepam for the control of emesis in patients receiving cytotoxic chemotherapy.
    Bishop JF; Wolf M; Matthews JP; Scott K; Ackland S; Yuen K; Morton C; Hillcoat BL; Cooper IA
    Cancer Treat Rep; 1987 Nov; 71(11):1007-11. PubMed ID: 3315193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of intermittent ondansetron versus continuous infusion metoclopramide used with standard combination antiemetics in control of acute nausea induced by cisplatin chemotherapy.
    Navari RM; Province WS; Perrine GM; Kilgore JR
    Cancer; 1993 Jul; 72(2):583-6. PubMed ID: 8319191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controlling delayed vomiting: double-blind, randomized trial comparing placebo, dexamethasone alone, and metoclopramide plus dexamethasone in patients receiving cisplatin.
    Kris MG; Gralla RJ; Tyson LB; Clark RA; Cirrincione C; Groshen S
    J Clin Oncol; 1989 Jan; 7(1):108-14. PubMed ID: 2642536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pilot study of metoclopramide, dexamethasone, diphenhydramine and lorazepam in prevention of nausea and vomiting in cisplatin-treated male patients.
    Roila F; Basurto C; Bracarda S; Picciafuoco M; Ballatori E; Del Favero A; Tonato M
    Oncology; 1990; 47(5):415-7. PubMed ID: 2216296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amelioration of cytotoxic-induced emesis with high-dose metoclopramide, dexamethasone and lorazepam.
    Palmer MC; Colls BM
    Cancer Chemother Pharmacol; 1987; 19(4):331-4. PubMed ID: 3297375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effective control of cisplatin induced emesis by combination drug regimen.
    Misra R; Agarwal N
    Indian J Cancer; 1994 Mar; 31(1):19-22. PubMed ID: 8063331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cinnarizine for prevention of nausea and vomiting during platin chemotherapy.
    Wilder-Smith CH; Schimke J; Osterwalder B; Senn HJ
    Acta Oncol; 1991; 30(6):731-4. PubMed ID: 1958394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.